Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML)
In brief
This is a randomized double blind placebo controlled study of azacitidine with or without birinapant in subjects with higher risk Myelodysplastic syndrome, secondary MDS or myelomonocytic leukemia (CMMoL) who are naïve, to azacitidine therapy. Pre-clinical and mechanistic studies support that azacitidine may modulate pathways that enable birinapant-mediated anti-tumor activity.
Key facts
- Study ID
- NCT02147873
- Run by
- TetraLogic Pharmaceuticals
- People needed
- 118
- Starts
- 2014-06-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2016-10-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Center for Cancer Care — Glendale, Arizona, United States
- Mayo Clinic — Scottsdale, Arizona, United States
- Arizona Oncology Associates — Tucson, Arizona, United States
- Ronald Reagan UCLA Medical Center — Los Angeles, California, United States
- North County Oncology — Oceanside, California, United States
- Desert Hematology Oncology Medical Group — Rancho Mirage, California, United States
- Stanford Hospital and Clinics — Stanford, California, United States
- Wellness Oncology & Hematology — West Hills, California, United States
- Colorado Blood Cancer Institute — Denver, Colorado, United States
- Cancer Specialists of North Florida — Jacksonville, Florida, United States
- Mayo Clinic Jacksonville — Jacksonville, Florida, United States
- Hematology Oncology Associates of the Treasure Coast — Port Saint Lucie, Florida, United States
- H. Lee Moffitt Cancer Center & Research Institute — Tampa, Florida, United States
- Bond Clinic PA — Winter Haven, Florida, United States
- Loyola University Medical Center — Maywood, Illinois, United States
- Simmons Cancer Institute at Southern Illinois University — Springfield, Illinois, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- University of Louisville Hospital/James Graham Brown Cancer Center — Louisville, Kentucky, United States
- Tulane Medical Center — New Orleans, Louisiana, United States
- University of Maryland, Greenebaum Cancer Center — Baltimore, Maryland, United States
- University of Massachusetts Worcester — Worcester, Massachusetts, United States
- St. Joseph Mercy Hospital — Ann Arbor, Michigan, United States
- New Jersey Hematology Oncology Associates — Brick, New Jersey, United States
- Hackensack University Medical Center — Hackensack, New Jersey, United States
- Palo Verde Hematology Oncology — Glendale, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.